In vitro evaluation of alginate beads of a diclofenac salt

International Journal of Pharmaceutics

Volumn 163, Issue 1-2, 1998, Pages 23-34

  Fernandez Hervas M J ^a   Holgado, M A ^a   Fini, A ^b   Fell, J T ^c  

^a UNIVERSITY OF SEVILLE   (Spain)

^b Istituto di Scienze Chimiche   (Italy)

^c UNIVERSITY OF MANCHESTER   (United Kingdom)

Author keywords

Chitosan; Controlled release; Eudragit L30D; Interpolymeric complex; Multiple unit system; Sodium alginate

Indexed keywords

ALGINIC ACID; CALCIUM CHLORIDE; CHITOSAN; DICLOFENAC; EUDRAGIT;

ARTICLE; COMPLEX FORMATION; CONTROLLED RELEASE FORMULATION; DRUG BIOAVAILABILITY; DRUG FORMULATION; DRUG RELEASE; DRUG SOLUBILITY; ENTERIC COATED TABLET; INTESTINE ABSORPTION; MOLECULAR WEIGHT; PRIORITY JOURNAL; SUSTAINED RELEASE PREPARATION;

EID: 0345215167     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0378-5173(97)00333-5     Document Type: Article

References (18)

1. Bechgaard H., Ladefoged K. Distribution of pellets in the gastro-intestinal tract. The influence on transit-time exerted by the density or diameter of pellets. J. Pharm. Pharmacol. 30:1978;690-692.
2. Berthold A., Cremer K., Kreuter J. Preparation of characterization of chitosan microspheres as drug carrier for prednisolone sodium phosphate as model for anti-inflammatory drugs. J. Control. Release. 39:1996;17-25.
3. Clarke G.M., Newton J.M., Short M.D. Gastro intestinal transit of pellets of differing size and density. Int. J. Pharm. 10:1993;81-92.
4. Coupe A.J., Davis S.S., Wilding I.R. Variation in gastrointestinal transit of pharmaceutical dosage form in healthy subject. Pharm. Res. 8:1991;360-364.
5. Filipovic-Grcic J., Becirevic-Lacan M., Skalko N., Jalsenjak I. Chitosan microspheres of nifedipine and nifedipine-cyclodextrin inclusion complexes. Int J Pharm. 135:1996;183-190.
6. Folkier N., Doelker E. Biopharmaceutical comparison of oral multiple-unit and single-unit sustained-release dosage form. STP Pharma. Sci. 2:1986;141-158.
7. Hogan, J.E., Aulton A. (Eds.), 1995. Pharmaceutical coating technology. Taylor and Francis, 409-438.
8. Imai T., Shiraishi S., Saito H., Otagiri M. Interaction of indomethacin with low molecular weight chitosan and improvements of some pharmaceutical properties of indomethacin by low molecular weight chitosans. Int. J. Pharm. 67:1991;11-20.
9. Li X. The use of chitosan to increase the stability of calcium alginate beads with entrapped yeast cells. Biotechnol. Appl. Biochem. 23:1996;269-271.
10. Lin S.Y., Kao Y.H. Tablet formulation study of spray-dried sodium diclofenac enteric-coated microcapsules. Pharm. Res. 8:1991;919-924.
11. Lin L., Lin S., Ng S., Froix M., Ohmo T., Heller J. Controlled release of interleukin-2 for tumour inmunotherapy using alginate/chitosan porous microspheres. J. Control. Release. 43:1997;65-74.
12. Okada M., Suzuki M., Ono K., Kasai S., Iwasa A. Dissolution mechanism and optimization of enteric coated long acting diclofenac sodium preparation. Proc. Int. Symp. Control. Rel. Bioact. Mater. 23:1996;559-560.
13. Polk A., Amsden B., De Yao K., Peng T., Goosen M.F.A. Controlled release of albumin from chitosan-alginate microcapsules. J. Pharm. Sci. 83:1994;178-185.
14. Scholer D.W., Ku E.C., Boettacher I., Schweizer A. Pharmacology of diclofenac sodium. Am. J. Med. 80:1986;34-38.
15. Smidsrod O, Skjak-Braek S. Alginate as immobilization materials. Trend Biotechnol. 8:1990;71-78.
16. Torres D., García-Encina G., Seijo B., Vila-Jato J.L. Biopharmaceutical evaluation of microencapsulate ion-exchange resins containing diclofenac. Eur. J. Pharm. Biopharm. 41:1995;127-131.
17. Yotsuyanagi T., Yoshioka I., Segi N., Ikeda K. Acid-induced and calcium-induced gelation of alginic acid: Bead formation and pH dependent swelling. Chem. Pharm. Bull. 39:1991;1072-1074.
18. Vilivalam V.D., Adeyeye C.M. Development and evaluation of controlled-release diclofenac micropheres and tabletted microspheres. J. Micoencapsulation. 11:1994;455-470.